Jane Street’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Jane Street’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,040	Closed	-$216K	–	5077
2016 Q1	$216K	Buy	+4,040	New	+$298K	﹤0.01%	3616
2015 Q4	–	Sell	-6,329	Closed	-$697K	–	4914
2015 Q3	$745K	Sell	6,329 -7,748	-55%	-$1.01M	﹤0.01%	1888
2015 Q2	$1.09M	Buy	14,077 +1,356	+11%	+$88.9K	0.01%	1468
2015 Q1	$736K	Buy	+12,721	New	+$540K	0.01%	1651
2014 Q3	–	Sell	-10,611	Closed	-$188K	–	3611
2014 Q2	$188K	Buy	+10,611	New	+$171K	﹤0.01%	2229

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Jane Street's ANAC Position: Q2 2016 in Review

Jane Street sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 4,040 shares — an estimated $216K sold.

Jane Street first reported a position in ANAC in Q2 2014 and held it in 5 quarters. The position peaked at $1.09M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Jane Street reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Jane Street sold 4,040 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $216K.
Jane Street first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2014 and held it in 5 quarters.
Jane Street's ANACOR PHARMACEUTICALS INC COM position peaked at $1.09M in Q2 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Jane Street's 13F filing for Q2 2016, filed 15 Aug 2016.